Building on the momentum of previous editions, the congress will provide a platform to share advances in cancer research, strengthen connections across disciplines, and accelerate the translation of molecular insights into clinical practice.

Through keynote sessions, discussions, and networking opportunities, participants will engage with the evolving landscape of precision oncology and its impact on patient care worldwide.

Organised by Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO), and Unicancer, MAP 2026 promises to be a landmark meeting where science, medicine, and collaboration converge to shape the future of oncology.